Literature DB >> 10457734

Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome.

C Myers1, D Wilks.   

Abstract

The objective of the study was to compare the Euroqol EQ-5D (Euroqol) and short-form 36 (SF-36) health questionnaires in patients with chronic fatigue syndrome (CFS). One hundred and twenty-seven outpatients referred to a hospital-based infectious disease clinic with a diagnosis of CFS were contacted by post and asked to complete both questionnaires. Additional data were determined from hospital casenotes. Eighty-five patients returned correctly completed questionnaires. Euroqol health values and visual analogue scale (VAS) scores were strongly and significantly correlated with all dimensions of the SF-36, with the exception of physical limitation of role. SF-36 dimensions were in turn strongly and significantly correlated with each other, with the same exception. Patients reported a high degree of physical disability and a moderate degree of emotional or psychological ill-health. The Euroqol elements dealing with mobility and self-care referred to inappropriately severe degrees of disability for these patients with CFS. Similarly some dimensions in the SF-36 were oversensitive and did not discriminate between patients with moderate or severe disability. It was concluded that Euroqol scores correlated strongly with SF-36 scores and provided useful information about patients with CFS and that Euroqol would be a useful tool for the rapid assessment of health status in CFS. The current Euroqol instrument refers to inappropriately severe degrees of disability for patients with CFS and would need to be modified to be maximally useful in this situation.

Entities:  

Mesh:

Year:  1999        PMID: 10457734     DOI: 10.1023/a:1026459027453

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Variations in population health status: results from a United Kingdom national questionnaire survey.

Authors:  P Kind; P Dolan; C Gudex; A Williams
Journal:  BMJ       Date:  1998-03-07

3.  Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.

Authors:  A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates
Journal:  Am J Med       Date:  1996-09       Impact factor: 4.965

4.  Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.

Authors:  D Buchwald; T Pearlman; J Umali; K Schmaling; W Katon
Journal:  Am J Med       Date:  1996-10       Impact factor: 4.965

5.  Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

Authors:  J Brazier; N Jones; P Kind
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

6.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

7.  Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue.

Authors:  P Manu; G Affleck; H Tennen; P A Morse; J I Escobar
Journal:  Psychother Psychosom       Date:  1996 Mar-Apr       Impact factor: 17.659

8.  Using the SF-36 and Euroqol on an elderly population.

Authors:  J E Brazier; S J Walters; J P Nicholl; B Kohler
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

9.  The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

Authors:  A M Garratt; D A Ruta; M I Abdalla; J K Buckingham; I T Russell
Journal:  BMJ       Date:  1993-05-29

10.  A report--chronic fatigue syndrome: guidelines for research.

Authors:  M C Sharpe; L C Archard; J E Banatvala; L K Borysiewicz; A W Clare; A David; R H Edwards; K E Hawton; H P Lambert; R J Lane
Journal:  J R Soc Med       Date:  1991-02       Impact factor: 18.000

View more
  27 in total

1.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.

Authors:  J L Bosch; M G Hunink
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan.

Authors:  Sheng-Tsung Yu; Hsing-Yi Chang; Kai-Ping Yao; Yu-Hsuan Lin; Baai-Shyun Hurng
Journal:  Qual Life Res       Date:  2015-04-02       Impact factor: 4.147

3.  EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36.

Authors:  A Nordlund; K Ekberg; M Kristenson
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

4.  The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.

Authors:  Chen-Wei Pan; Hong-Peng Sun; Xingzhi Wang; Qinghua Ma; Yong Xu; Nan Luo; Pei Wang
Journal:  Qual Life Res       Date:  2014-12-25       Impact factor: 4.147

5.  Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients.

Authors:  Anne Kaarlola; Ville Pettilä; Pertti Kekki
Journal:  Intensive Care Med       Date:  2004-11-03       Impact factor: 17.440

6.  Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.

Authors:  S Trippoli; M Vaiani; C Lucioni; A Messori
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Measuring substantial reductions in functioning in patients with chronic fatigue syndrome.

Authors:  Leonard Jason; Molly Brown; Meredyth Evans; Valerie Anderson; Athena Lerch; Abigail Brown; Jessica Hunnell; Nicole Porter
Journal:  Disabil Rehabil       Date:  2010-07-09       Impact factor: 3.033

Review 8.  Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kirstie L Haywood; Sophie Staniszewska; Sarah Chapman
Journal:  Qual Life Res       Date:  2011-05-18       Impact factor: 4.147

9.  Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Authors:  Roger Jones; Silke Horbach; Peter Sander; Tina Rydén-Bergsten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Feasibility and reliability of health-related quality of life measurements among tuberculosis patients.

Authors:  M J Dion; P Tousignant; J Bourbeau; D Menzies; K Schwartzman
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.